According to Brittany Lubeck, MS, RD, “At times, supplements bought at a store can be a little scary to take because their ingredients are not regulated, so we don’t really know what we are taking when we swallow them.” Making Supplements at Home Making supplement powders at home will mean women can rest easy knowing… Read More: Home-Made Food Supplements: Choosing the Right Combination »
Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More: Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in… »
Adoptive cell transfer (ACT) is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients. ACT is already available in the clinic for some diseases — CAR… Read More: Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model »
November 20, 2018 Share this content: A higher blood eosinophil count was associated with a greater protective effect of ICS/LABA/LAMA against severe acute COPD exacerbations. A combination of inhaled corticosteroids (ICS)/long-acting β2-agonist (LABA)/long-acting muscarinic receptor antagonist (LAMA) is possibly more effective than a LABA/LAMA combination or single long-acting bronchodilator therapy in reducing the risk for… Read More: Which Drug Combination Works Best to Reduce Acute COPD Exacerbations? »